Home/Investors/Novo Holdings Novo Holdings
Biotech Investor · 15 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Ribon Therapeutics | phase-2 | — | Oncology, Immunology |
| Vita Therapeutics | preclinical | — | Cardiovascular, Regenerative Medicine |
| Zencore Biologics | platform | — | Oncology, Immunology |
| Numab Therapeutics | phase-2 | — | Oncology, Immunology |
| Belharra Therapeutics | preclinical | — | Oncology, Immunology |
| Kivu Bioscience | Pre-clinical | — | Oncology |
| Anokion | Phase 2 | — | Autoimmune Diseases, Celiac Disease |
| F2G | Phase 3 | — | Infectious Disease, Rare Diseases |
| Myricx Bio | Pre-clinical | — | Oncology |
| Hoba Therapeutics | Pre-clinical | — | Chronic Pain, Sensorineural Hearing Loss |
| STipe Therapeutics | Pre-clinical | — | Oncology |
| MinervaX | phase-2 | — | Infectious Disease |
| TheraCell | phase-1 | — | Orthopedics, Cardiovascular |
| Soufflé Therapeutics | phase-2 | — | Oncology, Immunology |
| BioRegen | phase-2 | — | Regenerative Medicine, Autoimmune |